PE33396A1 - Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar - Google Patents

Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Info

Publication number
PE33396A1
PE33396A1 PE1995272088A PE27208895A PE33396A1 PE 33396 A1 PE33396 A1 PE 33396A1 PE 1995272088 A PE1995272088 A PE 1995272088A PE 27208895 A PE27208895 A PE 27208895A PE 33396 A1 PE33396 A1 PE 33396A1
Authority
PE
Peru
Prior art keywords
nicotine
composition
ansia
smoking
symptoms
Prior art date
Application number
PE1995272088A
Other languages
English (en)
Spanish (es)
Inventor
Satyanarayana Majeti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE33396A1 publication Critical patent/PE33396A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PE1995272088A 1994-06-23 1995-06-22 Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar PE33396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26426294A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
PE33396A1 true PE33396A1 (es) 1996-08-19

Family

ID=23005260

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995272088A PE33396A1 (es) 1994-06-23 1995-06-22 Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar

Country Status (6)

Country Link
AU (1) AU2703695A (xx)
IL (1) IL114129A0 (xx)
MA (1) MA23588A1 (xx)
PE (1) PE33396A1 (xx)
WO (1) WO1996000071A1 (xx)
ZA (1) ZA955032B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
AU2002363947A1 (en) 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20110053988A1 (en) * 2009-08-29 2011-03-03 Jorge Alberto Cassara Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
CN109069649A (zh) * 2016-04-12 2018-12-21 A·索利斯·赫雷拉 用烟碱乙酰胆碱受体激动剂治疗鼻和鼻旁粘膜病症的组合物和方法
EP3781191A4 (en) * 2018-04-16 2022-01-19 Barista Mist Pty Ltd CAFFEINE COMPOSITIONS AND METHODS OF USE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
ZA955032B (en) 1996-03-11
IL114129A0 (en) 1995-10-31
MA23588A1 (fr) 1995-12-31
AU2703695A (en) 1996-01-19
WO1996000071A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
HK1003978A1 (en) Composition for the treatment of schizophrenia
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
ES2167453T3 (es) Composicion de suministro medicamentoso que contiene quitosano o derivado del mismo con un potencial z. definido.
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
AR020803A1 (es) Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
PE68899A1 (es) Composicion que contiene paracetamol
ES8305363A1 (es) Un procedimiento para preparar una composicion farmaceutica que contiene 9-(2-hidroxietoximetil)guanina.
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ES2142430T3 (es) Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
BR0111325A (pt) processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco
ES2039433T3 (es) Una formulacion farmaceutica.
ATE81462T1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
KR920702225A (ko) 약학 조성물
ES2082023T3 (es) Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
KR920014474A (ko) 담석 붕괴용 제제
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ES2128353T3 (es) Composicion topica que contiene penciclovir.
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
SE8206728D0 (sv) Lekemedelspreparat

Legal Events

Date Code Title Description
FD Application declared void or lapsed